Fundraising FoxMERGING TRAFFIC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Continuity Biosciencescontinuitybiosciences.comAug 2025SEC filingmedium confidence
Continuity Biosciences develops adaptive precision drug-delivery platforms that combine engineering and biology to help therapies reach their intended targets more effectively.
BiotechDeep TechMedical DevicesBradenton, US
Ramakrishna Venugopalan(Co-Founder & Chief Executive Officer)Robert Whitehead(Co-Founder & Executive Chair)
BoardAlessandro Grattoni(Chief Scientific Advisor)
Board seatAllen R. Weiss· per SEC Form D · $12M raise · filed Aug 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.